GO:0052834 inositol monophosphate phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0052834 describes the catalytic activity that removes a phosphate group from myo-inositol phosphate to produce myo-inositol and free phosphate.
• This activity is essential for inositol recycling and phosphatidylinositol signaling, influencing cellular stress responses and metabolic homeostasis.
• Enzymes with this activity are found across bacteria, archaea, and eukaryotes, and some exhibit dual specificity toward other phosphorylated substrates.
• In humans, inositol monophosphate phosphatase activity has been linked to metabolic diseases such as diabetic nephropathy and to neuronal signaling.
• Zinc and magnesium ions modulate the activity of several inositol monophosphatases, revealing metal-dependent regulatory mechanisms.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of gene function related to this GO term.
Description
Inositol monophosphate phosphatase activity (GO:0052834) is a molecular function that catalyzes the hydrolysis of myo-inositol phosphate to myo-inositol and inorganic phosphate. This reaction is a critical step in the phosphatidylinositol signaling cycle and in inositol homeostasis, processes that regulate diverse cellular functions including membrane trafficking, ion channel activity, and stress responses. Researchers study this activity to understand how cells recycle inositol and how perturbations contribute to metabolic and neurological disorders. The enzyme activity is conserved from bacteria to humans, and in some organisms it is carried out by proteins with additional phosphatase activities, such as 3'-phosphoadenosine 5'-phosphate (PAP) phosphatase or tyrosine phosphatase activity. Because of its central role in lipid signaling, inositol monophosphate phosphatase activity is a target of interest for therapeutic development in diabetes, cancer, and neurodegenerative conditions.
inositol monophosphate phosphatase activity At A Glance
| GO ID | GO:0052834 |
|---|---|
| GO term | inositol monophosphate phosphatase activity |
| Ontology | molecular_function |
| Synonym | inositol-1(or 4)-monophosphatase activity; myo-inositol monophosphatase activity; inositol-phosphate phosphatase activity |
| Major function | Hydrolysis of myo-inositol phosphate to myo-inositol and phosphate |
| Reaction | myo-inositol phosphate + H2O = myo-inositol + phosphate |
| Cofactors | Mg2+ or Zn2+ dependent in some enzymes |
| Subcellular location | Cytosol and membrane-associated in various organisms |
| Related pathways | Phosphatidylinositol signaling, inositol recycling, stress response |
What Is GO:0052834?
According to the Gene Ontology, GO:0052834 is defined as the catalysis of the reaction: myo-inositol phosphate + H2O = myo-inositol + phosphate. In other words, it is the enzymatic removal of a phosphate group from an inositol phosphate molecule, yielding free myo-inositol and phosphate. This activity is also known by synonyms such as inositol-1(or 4)-monophosphatase activity, myo-inositol monophosphatase activity, and inositol-phosphate phosphatase activity.
Why Is inositol monophosphate phosphatase activity Important in Cell Biology?
Inositol monophosphate phosphatase activity is important because it directly controls the availability of myo-inositol, a precursor for phosphatidylinositol and its phosphorylated derivatives that act as signaling molecules. Dysregulation of this activity has been implicated in metabolic diseases such as diabetic nephropathy, where inositol metabolism is altered, and in neuronal function, where inositol monophosphatase contributes to phosphoinositide signaling. Moreover, the enzyme is a validated target for mood stabilizers like lithium, although the exact therapeutic mechanism remains under investigation. Understanding this activity at the molecular level can inform drug discovery and precision medicine approaches.
• Regulates inositol recycling and phosphatidylinositol signaling, impacting cell growth and survival.
• Linked to metabolic disorders including diabetic nephropathy and insulin resistance.
• Contributes to neuronal signaling and has been studied in the context of mood disorders.
• Some enzymes with this activity also hydrolyze PAP and inositol bisphosphate, connecting to sulfation and lipid signaling.
• Archaeal and eubacterial homologs provide insights into evolution and dual-substrate specificity.
• Zinc-dependent acid phosphatases can exhibit myo-inositol-1-phosphatase activity, expanding the repertoire of metal-dependent phosphatases.
• Potential target for therapeutic intervention in cancer cell migration and invasion.
• Essential for Mycobacterium tuberculosis inositol metabolism, with implications for tuberculosis drug development.
Molecular Mechanism of inositol monophosphate phosphatase activity
Substrate recognition and binding
In simple terms: The enzyme grabs a myo-inositol phosphate molecule and positions it for phosphate removal.
Inositol monophosphate phosphatases recognize myo-inositol phosphate as a substrate through a conserved active site that accommodates the inositol ring and the phosphate group. Structural studies of dual-activity PAP phosphatase-1 from Entamoeba histolytica revealed a fold that can bind both 3'-phosphoadenosine 5'-phosphate and inositol 1,4-bisphosphate, indicating a broad substrate-binding pocket. In Mycobacterium tuberculosis, multiple genes encode inositol monophosphate phosphatases, suggesting specialized substrate handling.
Catalytic hydrolysis
In simple terms: A water molecule attacks the phosphate, breaking the bond and releasing free phosphate.
The catalytic mechanism involves nucleophilic attack by a water molecule on the phosphate group of myo-inositol phosphate, facilitated by metal ions such as Mg2+ or Zn2+. This results in the cleavage of the phosphoester bond and release of myo-inositol and inorganic phosphate. Some enzymes, like the archaeal inositol monophosphatase, also exhibit NADP(H) phosphatase activity, indicating a broader phosphohydrolase capability.
Metal ion dependence and regulation
In simple terms: Metal ions like zinc or magnesium help the enzyme work and can switch its activity.
Many inositol monophosphate phosphatases require divalent metal ions for activity. For example, a zinc-ion-dependent acid phosphatase from rat brain exhibits magnesium-ion-dependent myo-inositol-1-phosphatase activity, and myo-inositol monophosphatase in the brain can display zinc-ion-dependent tyrosine phosphatase activity. This metal dependence provides a regulatory layer that can be exploited for selective inhibition.
Dual-substrate specificity and broader roles
In simple terms: Some versions of the enzyme can act on other molecules besides inositol phosphates.
Certain enzymes with inositol monophosphate phosphatase activity also hydrolyze other substrates. For instance, PAP phosphatase-1 from Entamoeba histolytica can hydrolyze both 3'-phosphoadenosine 5'-phosphate and inositol 1,4-bisphosphate. Similarly, archaeal inositol monophosphatase and eubacterial PAP phosphatase share NADP(H) phosphatase activity. This dual specificity suggests roles beyond inositol recycling, including regulation of sulfation and redox balance.
Key Genes Involved in GO:0052834 inositol monophosphate phosphatase activity
The following genes encode proteins with inositol monophosphate phosphatase activity or are closely related to its function, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IMPA1 | Inositol monophosphatase 1; hydrolyzes myo-inositol phosphate | Central to inositol recycling and phosphatidylinositol signaling |
| IMPA2 | Inositol monophosphatase 2; similar activity | Associated with neuronal signaling and mood disorders |
| IMPA3 | Inositol monophosphatase 3; involved in inositol metabolism | Potential role in metabolic diseases |
| INPP4B | Lipid phosphatase; controls pancreatic cancer cell migration | Regulates fibronectin exocytosis; cancer invasion |
| PAP phosphatase-1 (Eh) | Dual-activity phosphatase in Entamoeba histolytica | Hydrolyzes PAP and inositol bisphosphate |
| Mt-IMPase genes | Multiple inositol monophosphate phosphatases in M. tuberculosis | Essential for inositol metabolism; drug target |
| Archaeal IMPase | Inositol monophosphatase with NADP(H) phosphatase activity | Model for dual-substrate enzymes |
| Zinc-dependent acid phosphatase | Exhibits myo-inositol-1-phosphatase activity | Metal-dependent regulation |
| Brain IMPase | myo-inositol monophosphatase with tyrosine phosphatase activity | Neuronal signaling and zinc regulation |
| IMPA1 (human) | Major inositol monophosphatase in brain and periphery | Target for lithium and mood stabilizers |
| IMPA2 (human) | Inositol monophosphatase 2 | Genetic associations with bipolar disorder |
| INPP4B (human) | Inositol polyphosphate 4-phosphatase type II | Tumor suppressor or oncogene context-dependent |
| PAP phosphatase (bacterial) | 3'-phosphoadenosine 5'-phosphate phosphatase | Shares activity with inositol monophosphatase |
| IMPase (M. tuberculosis) | Inositol monophosphate phosphatase | Required for growth and virulence |
| IMPase (Entamoeba) | Dual-specificity phosphatase | Potential drug target in amoebiasis |
How Is inositol monophosphate phosphatase activity Regulated?
Inositol monophosphate phosphatase activity is regulated at multiple levels. Metal ion availability, particularly Mg2+ and Zn2+, directly modulates catalytic efficiency. In mammalian cells, the activity is influenced by lithium, which inhibits inositol monophosphatase and is used therapeutically in bipolar disorder. Additionally, expression levels of IMPA genes can be altered in metabolic diseases such as diabetic nephropathy, where Chinese medicine treatments have been shown to modulate inositol metabolism. In cancer, INPP4B activity is regulated by its lipid phosphatase domain and affects downstream signaling.
inositol monophosphate phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IMPA1 | Bipolar disorder, metabolic syndrome | Knockout mice, neuronal cell lines |
| IMPA2 | Psychiatric disorders | Point mutation knock-in in iPSCs |
| INPP4B | Pancreatic cancer, breast cancer | Overexpression and knockout in cancer cell lines |
| Mt-IMPase | Tuberculosis | Mycobacterium tuberculosis knockout strains |
| Eh-PAP phosphatase | Amoebiasis | Entamoeba histolytica knockdown |
Metabolic diseases and diabetic nephropathy
Inositol monophosphate phosphatase activity is linked to metabolic disorders. In diabetic nephropathy, altered inositol metabolism contributes to renal dysfunction, and therapeutic interventions with Chinese medicines have been shown to modulate these pathways. Myo-inositol supplementation has been proposed as a therapeutic strategy in metabolic diseases, highlighting the importance of inositol recycling enzymes.
Neurological and psychiatric disorders
In the brain, myo-inositol monophosphatase activity is critical for phosphoinositide signaling, and its inhibition by lithium is a cornerstone of bipolar disorder treatment. The enzyme also exhibits zinc-dependent tyrosine phosphatase activity, suggesting a role in neuronal signaling beyond inositol metabolism. Genetic variants in IMPA2 have been associated with psychiatric conditions, although the mechanisms remain under investigation.
Cancer and cell migration
The lipid phosphatase INPP4B, which shares functional overlap with inositol monophosphate phosphatases, controls pancreatic cancer cell migration and invasion by regulating fibronectin exocytosis. This indicates that enzymes in this family can influence tumor progression and metastasis, making them potential targets for cancer therapy.
Infectious diseases
In Mycobacterium tuberculosis, inositol monophosphate phosphatase genes are essential for inositol metabolism and bacterial survival, suggesting they could be targeted for tuberculosis treatment. Similarly, dual-activity phosphatases in Entamoeba histolytica are potential drug targets.
From inositol monophosphate phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of IMPA1 affect inositol levels? | CRISPR knockout in HEK293 or neuronal cells |
| How do point mutations in IMPA2 alter enzyme activity? | Point mutation knock-in in cell lines |
| Can tagged IMPA1 reveal subcellular localization? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
| Does overexpression of INPP4B affect cancer cell migration? | Overexpression in pancreatic cancer cell lines |
| What is the role of Mt-IMPase in bacterial survival? | CRISPR interference or knockout in M. tuberculosis |
| Can dual-activity phosphatases be selectively inhibited? | Knockout of one activity domain in Entamoeba |
How to Study the inositol monophosphate phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Malachite green assay | Free phosphate release | Enzyme kinetics and inhibitor screening |
| CRISPR knockout | Loss-of-function phenotype | Gene function studies in cell lines |
| X-ray crystallography | 3D structure of enzyme-substrate complex | Mechanistic insights and drug design |
| Metabolomics (LC-MS) | Myo-inositol and inositol phosphate levels | Pathway analysis in disease models |
| Western blot | Protein expression levels | Validation of knockout or overexpression |
| Immunofluorescence | Subcellular localization | Tagged knock-in cell lines |
| RNA-seq | Transcriptional changes | Global effects of gene perturbation |
Enzymatic activity assays
Inositol monophosphate phosphatase activity can be measured using colorimetric or fluorometric assays that detect released phosphate. These assays are often performed with purified recombinant enzymes or cell lysates, and they can be adapted to high-throughput screening for inhibitors.
Genetic knockout and knockdown
CRISPR-Cas9 knockout of genes encoding inositol monophosphatases (e.g., IMPA1, IMPA2) allows researchers to assess loss-of-function phenotypes, such as changes in inositol levels, phosphatidylinositol signaling, and cellular stress responses.
Structural biology and crystallography
X-ray crystallography and cryo-EM can resolve the structure of inositol monophosphate phosphatases bound to substrates or inhibitors, revealing active-site architecture and metal coordination. This approach has been used for PAP phosphatase-1 from Entamoeba histolytica.
Metabolomics and lipidomics
Mass spectrometry-based metabolomics and lipidomics quantify myo-inositol and phosphatidylinositol species, providing a readout of inositol monophosphate phosphatase activity in cells and tissues.
How CRISPR Can Be Used to Study GO:0052834 inositol monophosphate phosphatase activity
Knockout
CRISPR knockout of IMPA1, IMPA2, or INPP4B can abolish inositol monophosphate phosphatase activity, enabling studies of inositol depletion and downstream signaling. For example, knockout of IMPA1 in cell lines can reveal compensatory mechanisms and effects on phosphatidylinositol synthesis.
Point Mutation
Introducing point mutations in the catalytic domain of inositol monophosphatases (e.g., IMPA2) via CRISPR can dissect the contribution of specific residues to substrate binding and metal coordination. Such models are valuable for understanding disease-associated variants.
Knock-in
Knock-in of epitope tags (e.g., FLAG, GFP) at the endogenous locus of IMPA1 or INPP4B allows for real-time imaging and proteomic analysis of the enzyme in its native context. This approach preserves physiological regulation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of INPP4B or IMPA1 can model gain-of-function states, useful for studying cancer cell migration or metabolic reprogramming.
How EDITGENE Supports inositol monophosphate phosphatase activity Research
Researchers studying inositol monophosphate phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in inositol metabolism, signaling, or disease. Precise genetic models are essential to link enzyme activity to cellular phenotypes and to validate therapeutic targets.
Contact EDITGENE today to design your custom CRISPR model for inositol monophosphate phosphatase activity research.
Frequently Asked Questions About inositol monophosphate phosphatase activity
What is inositol monophosphate phosphatase activity?
It is the enzymatic activity that removes a phosphate group from myo-inositol phosphate to produce myo-inositol and phosphate, as defined by GO:0052834.
What genes are involved in inositol monophosphate phosphatase activity?
Key genes include IMPA1, IMPA2, IMPA3, and INPP4B in humans, as well as bacterial genes like those in Mycobacterium tuberculosis.
What is the GO ID for inositol monophosphate phosphatase activity?
The Gene Ontology ID is GO:0052834.
How is inositol monophosphate phosphatase activity regulated?
It is regulated by metal ions such as Mg2+ and Zn2+, and inhibited by lithium; expression can change in metabolic diseases.
What diseases are associated with inositol monophosphate phosphatase activity?
It has been linked to diabetic nephropathy, bipolar disorder, cancer progression, and infectious diseases like tuberculosis.
What is the reaction catalyzed by inositol monophosphate phosphatase?
The reaction is: myo-inositol phosphate + H2O = myo-inositol + phosphate.
Can inositol monophosphate phosphatases act on other substrates?
Yes, some enzymes also hydrolyze 3'-phosphoadenosine 5'-phosphate (PAP) and inositol bisphosphate, and may exhibit NADP(H) phosphatase activity.
How can I study inositol monophosphate phosphatase activity in the lab?
Common methods include enzymatic assays, CRISPR knockout, metabolomics, and structural biology.
What are the synonyms for inositol monophosphate phosphatase activity?
Synonyms include inositol-1(or 4)-monophosphatase activity, myo-inositol monophosphatase activity, and inositol-phosphate phosphatase activity.
Why is inositol monophosphate phosphatase activity important for drug discovery?
It is a target for mood stabilizers like lithium and potential therapies for metabolic diseases and cancer.
Conclusion
Inositol monophosphate phosphatase activity (GO:0052834) is a fundamental enzymatic function that regulates inositol recycling and phosphatidylinositol signaling. Its roles in metabolic diseases, neurological disorders, cancer, and infections make it a compelling subject for both basic and translational research. By leveraging CRISPR-based models and advanced analytical methods, researchers can uncover precise mechanisms and identify new therapeutic opportunities.
References
- 1. Tang G et al.. 2021. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.. Acta Pharm Sin B 11(9):2749-2767 PMID: 34589395
- 2. Croze ML et al.. 2013. Potential role and therapeutic interests of myo-inositol in metabolic diseases.. Biochimie 95(10):1811-27 PMID: 23764390
- 3. Movahedzadeh F et al.. 2010. Inositol monophosphate phosphatase genes of Mycobacterium tuberculosis.. BMC Microbiol 10:50 PMID: 20167072
- 4. Fujimoto S et al.. 1996. Zinc-ion-dependent acid phosphatase exhibits magnesium-ion-dependent myo-inositol-1-phosphatase activity.. Biol Pharm Bull 19(6):882-5 PMID: 8799493
- 5. Fujimoto S et al.. 1998. myo-Inositol monophosphatase in the brain has zinc ion-dependent tyrosine phosphatase activity.. Gen Pharmacol 31(3):469-75 PMID: 9703222
- 6. Saffi GT et al.. 2025. The lipid phosphatase INPP4B controls pancreatic cancer cell migration and invasion by regulating fibronectin exocytosis.. J Biol Chem 301(10):110716 PMID: 40962057
- 7. Faisal Tarique K et al.. 2014. Structural elucidation of a dual-activity PAP phosphatase-1 from Entamoeba histolytica capable of hydrolysing both 3'-phosphoadenosine 5'-phosphate and inositol 1,4-bisphosphate.. Acta Crystallogr D Biol Crystallogr 70(Pt 7):2019-31 PMID: 25004978
- 8. Fukuda C et al.. 2007. NADP(H) phosphatase activities of archaeal inositol monophosphatase and eubacterial 3'-phosphoadenosine 5'-phosphate phosphatase.. Appl Environ Microbiol 73(17):5447-52 PMID: 17616624
